MEDNAX's CEO Discusses Q1 2012 Results - Earnings Call Transcript


Q1 2012 Earnings Call

May 03, 2012 10:00 am ET


David Parker -

Roger J. Medel - Co-Founder, Chief Executive Officer, Director and Chairman of Executive Committee

Vivian Lopez-Blanco - Chief Financial Officer, Principal Accounting Officer and Treasurer

Karl Wagner - President of American Anesthesiology


Brian Zimmerman - Deutsche Bank AG, Research Division

Ryan Daniels - William Blair & Company L.L.C., Research Division

Joanna Gajuk - BofA Merrill Lynch, Research Division

Matthew J. Weight - Feltl and Company, Inc., Research Division

Brooks G. O'Neil - Dougherty & Company LLC, Research Division

Kevin K. Ellich - Piper Jaffray Companies, Research Division

Nicholas Jansen - Raymond James & Associates, Inc., Research Division

Ralph Giacobbe - Crédit Suisse AG, Research Division



Ladies and gentlemen, thank you very much for standing by, and welcome to the 2012 first quarter earnings conference call. [Operator Instructions] And also as a reminder, today's conference is being recorded. I would now like to turn the conference over to your host, Mr. David Parker. Please go ahead.

David Parker

Good morning, and welcome to MEDNAX 2012 First Quarter Earnings Call. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by MEDNAX's management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise.

If you liked this article you might like

Why the Boardroom Doesn't Need Ivy League Degrees

Mednax: Solid Growth at a Good Price

Analysts' Actions -- Kimberly-Clark, IberiaBank, Ionis Pharma, Actuant and More

How to Invest in Your Favorite MD